{"id":"NCT02980666","sponsor":"Shire","briefTitle":"Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support","officialTitle":"A 24-week Safety, Efficacy, Pharmacodynamic, and Pharmacokinetic Study of Teduglutide in Japanese Pediatric Subjects, Aged 4 Months Through 15 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01-13","primaryCompletion":"2020-01-21","completion":"2020-01-21","firstPosted":"2016-12-02","resultsPosted":"2021-02-10","lastUpdate":"2022-02-02"},"enrollment":10,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Teduglutide","otherNames":[]}],"arms":[{"label":"Teduglutide","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine if an investigational treatment (teduglutide) is safe and effective in Japanese children (age 4 months through 15 years of age) with SBS who are dependent on parenteral support. This study will also evaluate how teduglutide moves through the body (pharmacokinetics) and how it affects the body (pharmacodynamics).","primaryOutcome":{"measure":"Absolute Change From Baseline in Parenteral Support (PS) Volume at End of Treatment (EOT) Based on Dairy Data","timeFrame":"Baseline, EOT (up to Week 24)","effectByArm":[{"arm":"Total Children (Aged: 1 to 15 Years)","deltaMin":-11.8,"sd":8.47},{"arm":"Infants (Corrected Gestational Age: 4 to < 12 Months)","deltaMin":-26.2,"sd":13.61}],"pValues":[]},"eligibility":{"minAge":"4 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":20},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":["37364133"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":8},"commonTop":["Viral upper respiratory tract infection","Rash","Injection site erythema","Dry skin","Constipation"]}}